Recently, NASA provided licences to three Indian companies for manufacturing its ventilators for critical COVID-19 patients.
On Friday, the space organization named the three Indian companies as Alpha Design Technologies Pvt Ltd, Bharat Forge Ltd and Medha Servo Drives Pvt Ltd.
The NASA developed the ventilator specifically for coronavirus patients at its Jet Propulsion Laboratory (JPL) in Southern California. NASA is an independent agency for space research, aeronautics and related programmes in the US,
The engineers of JPL made VITAL, the special ventilator, within a month. Moreover, on April 30, JPL received ‘Emergency Use Authorization’ from the Food and Drug Administration.
As per the organization, the VITAL (Ventilator Intervention Technology Accessible Locally) equipment uses 1/7 of the parts of a traditional ventilator.
‘VITAL Provides An Affordable, Simple Solution For Treating Critical COVID-19 Patients’
The NASA statement said that the VITAL provides an affordable, simple solution for treating critical COVID-19 patients. With this, traditional ventilators would be left for symptomatic patients.
Leon Alkalai, manager of the JPL Office of Strategic Partnerships said that the VITAL team is very excited to see their technology licenced. He further hoped that this technology reaches globally and provides aid to this COVID-19 crisis.
According to NASA, VITAL was made with coordinated inputs of both doctors and manufacturers of the medical device.
On April 23, a JPL device’s prototype was tested successfully. Moreover, this test was conducted by the Human Simulation Lab in the Department of Anesthesiology, Perioperative and Pain Medicine at Mount Sinai.
A modified design, which uses compressed air and can be deployed by a greater range of hospitals, was recently tested at the UCLA Simulation Center in Los Angeles.
The NASA said that this device tested almost 20 different ventilator settings. Further, it said that these different ventilator setting represented a number of scenarios that could be seen in critical patients.
As per the doctors, VITAL has performed well in its simulation testing. “In addition, the setup and operation of the ventilator were quick and user-friendly,” said a media statement. It further said that the team of ULCA commends the active participation of JPC during COVID-19 crisis.